硕世生物(688399.SH)取得两项医疗器械注册证

Core Viewpoint - The company, Shuoshi Biotechnology (688399.SH), has received a medical device registration certificate from the National Medical Products Administration for two in vitro diagnostic products, enhancing its product offerings and competitive position in the market [1] Product Development - The newly registered products include the Adenovirus Antigen Test Kit (Colloidal Gold Method) and the Nucleic Acid Test Kit for Seven Respiratory Pathogens (Fluorescent PCR Method) [1] - The acquisition of these medical device registration certificates expands the company's portfolio in the in vitro diagnostic field [1] Market Positioning - The introduction of these products aims to meet diverse clinical needs, thereby strengthening the company's overall competitiveness [1] - This development is expected to enhance the company's market expansion capabilities [1]